P3H2
Basic information
Region (hg38): 3:189956728-190122437
Previous symbols: [ "LEPREL1" ]
Links
Phenotypes
GenCC
Source:
- myopia, high, with cataract and vitreoretinal degeneration (Strong), mode of inheritance: AR
- myopia, high, with cataract and vitreoretinal degeneration (Moderate), mode of inheritance: AR
Clinical Genomic Database
Source:
| Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
|---|---|---|---|---|---|
| Myopia, high, with cataract and vitreoretinal degeneration | AR | General | Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing | Ophthalmologic | 21885030; 24172257; 25469533 |
ClinVar
This is a list of variants' phenotypes submitted to
- not_provided (623 variants)
- Inborn_genetic_diseases (128 variants)
- P3H2-related_disorder (17 variants)
- Myopia,_high,_with_cataract_and_vitreoretinal_degeneration (14 variants)
- Myopia (1 variants)
- Rare_isolated_myopia (1 variants)
- Retinitis_pigmentosa (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the P3H2 gene is commonly pathogenic or not. These statistics are base on transcript: NM_000018192.4. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 131 | 142 | ||||
| missense | 301 | 11 | 320 | |||
| nonsense | 16 | 24 | ||||
| start loss | 0 | |||||
| frameshift | 18 | 22 | ||||
| splice donor/acceptor (+/-2bp) | 10 | |||||
| Total | 34 | 18 | 311 | 142 | 13 |
Highest pathogenic variant AF is 0.00015986616
GnomAD
Source:
| Gene | Type | Bio Type | Transcript | Coding Exons | Length |
|---|---|---|---|---|---|
| P3H2 | protein_coding | protein_coding | ENST00000319332 | 15 | 165710 |
| pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
|---|---|---|---|---|---|---|
| 7.79e-21 | 0.0133 | 125606 | 0 | 142 | 125748 | 0.000565 |
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
|---|---|---|---|---|---|---|
| Missense | -0.235 | 389 | 376 | 1.03 | 0.0000201 | 4529 |
| Missense in Polyphen | 110 | 98.896 | 1.1123 | 1182 | ||
| Synonymous | -0.643 | 155 | 145 | 1.07 | 0.00000792 | 1383 |
| Loss of Function | 0.771 | 34 | 39.2 | 0.867 | 0.00000227 | 451 |
LoF frequencies by population
| Ethnicity | Sum of pLOFs | p |
|---|---|---|
| African & African-American | 0.000844 | 0.000840 |
| Ashkenazi Jewish | 0.00 | 0.00 |
| East Asian | 0.000163 | 0.000163 |
| Finnish | 0.000324 | 0.000323 |
| European (Non-Finnish) | 0.000827 | 0.000827 |
| Middle Eastern | 0.000163 | 0.000163 |
| South Asian | 0.000461 | 0.000457 |
| Other | 0.000652 | 0.000652 |
dbNSFP
Source:
- Function
- FUNCTION: Prolyl 3-hydroxylase that catalyzes the post- translational formation of 3-hydroxyproline on collagens (PubMed:18487197). Contributes to proline 3-hydroxylation of collagen COL4A1 and COL1A1 in tendons, the eye sclera and in the eye lens capsule (By similarity). Has high activity with the type IV collagen COL4A1, and lower activity with COL1A1 (PubMed:18487197). Catalyzes hydroxylation of the first Pro in Gly-Pro-Hyp sequences where Hyp is 4-hydroxyproline (PubMed:18487197). Has no activity on substrates that lack 4- hydroxyproline in the third position (PubMed:18487197). {ECO:0000250|UniProtKB:Q8CG71, ECO:0000269|PubMed:18487197}.;
- Pathway
- Collagen biosynthesis and modifying enzymes;Collagen formation;Extracellular matrix organization
(Consensus)
Recessive Scores
- pRec
- 0.132
Intolerance Scores
- loftool
- rvis_EVS
- -0.55
- rvis_percentile_EVS
- 19.8
Haploinsufficiency Scores
- pHI
- 0.142
- hipred
- N
- hipred_score
- 0.394
- ghis
- 0.501
Essentials
- essential_gene_CRISPR
- essential_gene_CRISPR2
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- gene_indispensability_score
Mouse Genome Informatics
- Gene name
- P3h2
- Phenotype
- mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); vision/eye phenotype; homeostasis/metabolism phenotype;
Gene ontology
- Biological process
- negative regulation of cell population proliferation;peptidyl-proline hydroxylation;collagen metabolic process;oxidation-reduction process
- Cellular component
- basement membrane;endoplasmic reticulum;endoplasmic reticulum lumen;Golgi apparatus;sarcoplasmic reticulum
- Molecular function
- iron ion binding;procollagen-proline 3-dioxygenase activity;L-ascorbic acid binding